Gene · 2813
Papers2,809
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,809
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reduced fecal GP2 levels in ulcerative colitis associate with inflammatory activity and microbial composition. | Clin Chim Acta | 2027 | 42486317 | PubTator, text mining | PubMed |
| Dosimetric impact of coplanar and non-coplanar arc arrangements in VMAT-based lung SABR. | J Med Imaging Radiat Sci | 2026 | 42753370 | PubTator, text mining | PubMed |
| Development and immunological evaluation of a multi-antigen recombinant adenovirus vaccine candidate against PRRSV and PCV2. | BMC Vet Res | 2026 | 42675487 | PubTator, text mining | PubMed |
| Translating viral genetic data to PRRSV-2 cross-neutralization using machine learning. | Front Immunol | 2026 | 42500660 | PubTator, text mining | PubMed |
| Configurationally Locked Ridaifen-B Analogs as Potent Ebola Virus Entry Inhibitors. | J Med Chem | 2026 | 42475249 | PubTator, text mining | PubMed |
| Exposome factors predict the association between sleep health and depression. | medRxiv | 2026 | 42428082 | PubTator, text mining | PubMed |
| Long-term disease control of GP2-NTRK1 fusion-positive pancreatic adenocarcinoma with liver metastases using sequential tyrosine receptor kinase inhibitors. | Clin J Gastroenterol | 2026 | 42412359 | PubTator, text mining | PubMed |
| GCH1 p.Ser80Asn Confers Risk for Parkinson's Disease in East Asian Populations. | medRxiv | 2026 | 42396327 | PubTator, text mining | PubMed |
| Signal peptide cleavage and ectodomain regions of GP2 are required for PRRSV infection. | J Gen Virol | 2026 | 42313464 | PubTator, text mining | PubMed |
| In silico prioritization and cheminformatics identify structurally diverse small-molecule inhibitors of Lassa virus glycoprotein-mediated membrane fusion. | SLAS Discov | 2026 | 42285356 | PubTator, text mining | PubMed |
| Structural and genetic basis for broad antibody recognition of a protective epitope on orthomarburgvirus GP2. | Cell Rep | 2026 | 42284140 | PubTator, text mining | PubMed |
| An ancestry-enriched HNF4A variant and GP2 reveal distinct mechanisms of type 2 diabetes in exome-wide study of 13,674 cases and 41,024 controls. | medRxiv | 2026 | 42238389 | PubTator, text mining | PubMed |
| Spatially Resolved Molecular Subtyping Uncovers Tumor Progression and Immune Evasion Mechanisms in High-grade Serous Ovarian Cancer. | Cancer Res | 2026 | 42202064 | PubTator, text mining | PubMed |
| The Global Parkinson's Genetics Program (GP2): Advancing genetic discovery and capacity building worldwide. | J Parkinsons Dis | 2026 | 42159407 | PubTator, text mining | PubMed |
| A broadly-neutralizing antibody against Orthoebolavirus glycoprotein that potentiates the breadth and neutralization of other antibodies. | Npj Viruses | 2026 | 42098405 | PubTator, text mining | PubMed |
| Bridging Genetics and Precision Medicine in Parkinson's Disease through GP2. | medRxiv | 2026 | 42051573 | PubTator, text mining | PubMed |
| A Systematic Review and Meta-Analysis on the Global Seroprevalence of Porcine Reproductive and Respiratory Virus (PRRSV) in Pigs and Wild Boars: A Widespread and Impactful Swine Virus. | Vet Sci | 2026 | 41893721 | PubTator, text mining | PubMed |
| From Gut to Systemic Circulation: Molecular Strategies of Botulinum Neurotoxin Complexes. | Toxins (Basel) | 2026 | 41893539 | PubTator, text mining | PubMed |
| An alternative reverse genetics system for PRRS virus and its application to define the role of endocytic sorting signal in GP3 protein intracellular trafficking. | Front Microbiol | 2026 | 41883786 | PubTator, text mining | PubMed |
| Computational Design of Broad-Spectrum Ebola Antibodies through Framework and Complementarity-Determining Region Synergistic Optimization. | Research (Wash D C) | 2026 | 41878634 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2813/papers